Chris Boland - Avivagen Insider

Avivagen Inc -- Canada Stock  

CAD 0.85  0.00  0.00%


Mr. Chris Boland was appointed as Chief Financial Officer of Avivagen Inc., with effect from July 12, 2012
  CFO Since 2012      
Boland is a Canadian chartered accountant and also holds the certified management accountant designation. Prior to his present appointment, Mr. Boland was in public practice . Earlier positions at other organizations include general manager at Canada Post Corporationrationrationration, chief financial officer and vicepresident finance at Optiwave Corporationrationrationration, director of tax and treasury, controller, at Eftia OSS, manager of financial reporting and controller at the Canadian Bank Note, and manager of financial reporting at Mitel Corporationrationrationration. He was also an auditor at the Office of the Auditor General and manager at Treasury Board.

Management Efficiency

The company has return on total asset (ROA) of (83.76) % which means that it has lost $83.76 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (9.0) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 1.18 M in total debt. Avivagen Inc has Current Ratio of 5.47 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 5 records

CFO Since

Janice FukakusaRoyal Bank of Canada
Rod BolgerRoyal Bank of Canada
Riaz AhmedThe Toronto Dominion Bank
John WhelenEnbridge Inc
Sean McGuckinThe Bank of Nova Scotia

Entity Summary

Avivagen, Inc. develops and commercializes various solutions to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal?s own health defenses. Avivagen Inc (VIV) is traded on TSX Venture Exchange in Canada. It is located in Ottawa, ON KA R and employs 19 people.

Did you try this?

Run Fund Screener Now

Fund Screener

Find activelly-traded funds from around the world traded on over 30 global exchanges
Hide  View All  NextLaunch Fund Screener
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Avivagen Inc to your portfolio

Top Management

Avivagen Inc Leadership Team
David Hankinson, Director
Louis Hui, Director
Chris Boland, CFO
David Allan, Director
Amin Khalifa, Director
Aubrey Dan, Director
Cameron Groome, CEO
Vanessa Grant, Director
Andrew Basek, Director, MBA
Drew Basek, Director, MBA
Paul Mesburis, Director
Graham Burton, Director, Ph.D
G Anthony, Director

Stock Performance

Avivagen Performance Indicators